COVID-19 (coronavirus) vaccines have started becoming accessible in most countries and are probably a severe product in fighting the pandemic in 2021

1. COVID-19 VACCINE AND ITS DISTRIBUTION TO VARIOUS
GEOGRAPHIES
Healthcare & Life
Sciences

2. COVID-19 VACCINE AND ITS DISTRIBUTION TO VARIOUS
GEOGRAPHIES
COVID-19 pandemic has gravely affected the world economy.
The research institutes, pharmaceutical companies, and
healthcare organizations, together are working on the response,
tracing the pandemic, advising on crucial interventions, and
contributing to the distribution of the essential medical supplies
to patients. Moreover, the healthcare personnel are parallelly
engaged in the development and deployment of effective and
safe vaccines. With the rollout of vaccines, millions of lives can
be saved each year.
In a span of less than 12 months, post the beginning of the
COVID-19 pandemic, there were several research institutes and
pharmaceutical companies, started the development of vaccines
that protect from SARS-CoV-2, the virus that causes COVID-19.
The process for the development of a vaccine for the COVID-19
pandemic is much faster, compared to the other vaccine
development process. Within a year, several pharmaceutical
companies and research institutes have already announced the
successful development of a vaccine that are being approved for
use in various countries, including the US and India.
Pukka partners

3. COVID-19 Vaccine Delivery Challenge Worldwide
The scientific community's non-countable outstanding progress has brought the vaccine closer to consumer's doorstep at the
earliest. The stick now passes from the scientific community to a new collaborative effort, led by government & policymakers,
the private sector, healthcare professionals, and other community groups. The COVID-19 vaccine rollout will be different from
any other prior vaccine delivery effort. Governments and associated partners will be expected to rapidly accelerate their
efforts to ensure they can meet community expectations of efficient vaccine delivery at no extra time or cost.
▪ Multiple factors are carried out to make the COVID-19 vaccine rollout.
▪ Accelerated Pace and Giant Scale of Delivery
▪ Nations face a four-by-four challenge: a vaccine arriving at four times the pace and requiring delivery four times the scale.
Four times the pace – The coronavirus vaccine has been developed four times faster than the mumps vaccine, the previous
record for a vaccine developed for use in the broader public setting. The consequence of this rapid pace of clinical
development is that governments and policymakers have had far less time than previously to prepare for a robust vaccination
program. Four times the scale – The COVID-19 vaccine rollout is expected to be four times larger than any previous effort
because the aspiration is for broad adoption at significantly higher rates than typically achieved with seasonal adult vaccines,
such as the flu. Compared with the flu, roughly half the adult population across the OECD is protected each year with a single
dose. The COVID-19 condition may require vaccinating over half the adult population with two doses. Globally, it makes the
vaccine need for billions of people.

4. Pukka partners
Predicting and Modeling Outbreaks

5. Accelerated Pace and Giant Scale of Delivery
Nations face a four-by-four challenge: a vaccine arriving at four times the pace and requiring delivery four times the scale.
Four times the pace – The coronavirus vaccine has been developed four times faster than the mumps vaccine, the previous
record for a vaccine developed for use in the broader public setting. The consequence of this rapid pace of clinical development
is that governments and policymakers have had far less time than previously to prepare for a robust vaccination program.
Four times the scale – The COVID-19 vaccine rollout is expected to be four times larger than any previous effort because the
aspiration is for broad adoption at significantly higher rates than typically achieved with seasonal adult vaccines, such as the flu.
Compared with the flu, roughly half the adult population across the OECD is protected each year with a single dose. The COVID-
19 condition may require vaccinating over half the adult population with two doses. Globally, it makes the vaccine need for
billions of people.
Considering digital infrastructure to help through the COVID-19 pandemic
Various Nation's digital infrastructure requires strengthening to deal with the COVID-19 impact and future public health crises
Proper Artificial Intelligence (AI) integration into the public health response should be an urgency
Big data analysis involving disease transmission patterns, citizens' movement, and health monitoring to aid prevention
measures
Considering the past, the world has witnessed the rise of SARS, Ebola, Zika virus, and now COVID-19. This virus is a rising threat
to the communities.
Pukka partners

6. Pressure on Digital Infrastructure
Governments are now dependent on ubiquitous instruments (sensors) and authoritative algorithms instead of
flesh-and-blood spooks. To track the COVID-19 impact, several governments have hugely implemented systems
based on these new surveillance tools.
The world map also shows the decrease in people's transportation has drastically reduced carbon emissions
across different geographies, but what are the digital technologies emissions? Will the large volume of people
working from home (WFH) using digital systems in quarantine can cause or increase emissions from other fonts?
What is being done by the large cloud-service providers to address the capacity issue?
Pukka partners

7. Roadmap for a Better Future for Global Vaccination
The pandemic has provided a new start for digital infrastructure development across the globe. Using big data, cloud, and AI
applications creates room for industries to develop and shape new business models that benefit citizens in understanding
the severity of pandemic disease and ensure preventive measures.
A stakeholder (private and governmental) alliance also supports pharmaceutical enterprises with millions in funding to find
the most appropriate vaccine for the coronavirus virus. To modernize, upgrade and update the global digital infrastructure
and tackle the COVID-19 impact and future pandemics, different financial and supply chain models will evolve, such as
consumption/outcome-based public-private partnership models to ease the financial crisis during the development phase.
It is now the most accurate moment for global countries to accelerate the construction of new digital infrastructures, such
as AI, ML, big data, and IoT, in addition to the hastening of vital projects and major infrastructure construction that's already
included in countries' financial stimulus plans to ease the supply or distribution of vaccines and monitoring of the virus
impact worldwide.
Full Time Engagement

8. How We Are :-
Pukka Partners provide customized intelligence solutions to C-
suite executives and functional growth leaders, along with other
key offerings including market & competitive intelligence,
management & strategy consulting, pre-investment advisory,
real-time business intelligence, and data analytics services
across sectors, globally and locally, on new & emerging
markets and disruptive technologies.
We offer advisory and actionable insights around public
policies, investment tracking along with the obstacles faced by
investors, innovation and strategy impact monitoring,
identification of industry potential, and technology mapping
through comprehensive and standardized research
methodology and tools. We deploy our solutions to solve
prioritized and critical business challenges by leveraging our in-
house expertise and continuous engagement with industry
thought leaders in the business ecosystem.
Contact Us:- engage@pukkapartners.com
https://www.pukkapartners.com